Fundz

Crossbow Therapeutics reported raising $30.3 Million in an initial SEC Form D filing, from an offering of $80 Million

PRIVATESep 30, 2025$30.3M of $80M raised

Amount Raised

$30.3 Million

$30.3 Million sold, per SEC Form D (first sale Sep 17, 2025)

Round Type

Venture

CambridgeBiotechnologyHealth Care

Quick answer

Crossbow Therapeutics raised $30.3 Million in a funding round, dated September 17, 2025. Crossbow Therapeutics is based in Cambridge, Massachusetts, United States.

How much did Crossbow Therapeutics raise?
Crossbow Therapeutics raised $30.3 Million in a funding round on September 17, 2025.
What does Crossbow Therapeutics do?
Crossbow Therapeutics, Inc., is a biotechnology company determined to improve the lives of people with cancer by unlocking the therapeutic potential of T-cell receptor (TCR)-mimetic antibodies.
Where is Crossbow Therapeutics based and how big is it?
Crossbow Therapeutics is based in Cambridge, Massachusetts, United States. Fundz records about 41 employees.
Who are the decision-makers at Crossbow Therapeutics?
Fundz holds 1 contact at Crossbow Therapeutics. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Biotechnology and Health Care around the same time

Companies in the same sectors as Crossbow Therapeutics that raised within 45 days of this round, from Fundz verified event records.

  • Sernova raised $345K (Seed) on October 31, 2025.
  • Intensity Therapeutics raised $4M (Post-IPO Equity) on October 31, 2025.
  • Creative Medical Technology Holdings raised $4.2M (Funding Round) on October 31, 2025.
  • Zetagen Therapeutics raised $13M on October 31, 2025.
  • Prelude raised $5M on October 30, 2025.
  • Surgical Automations raised $3.4M (Seed) on October 30, 2025.

Who to call at Crossbow Therapeutics, and when

A new round usually means Crossbow Therapeutics is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Crossbow Therapeutics raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Crossbow Therapeutics, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Crossbow Therapeutics. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Crossbow Therapeutics

Location

Cambridge, Massachusetts, United States

About

Crossbow Therapeutics, Inc., is a biotechnology company determined to improve the lives of people with cancer by unlocking the therapeutic potential of T-cell receptor (TCR)-mimetic antibodies. The company’s T-Bolt™ therapies are next-generation, easily assembled immunotherapies directed with high precision at previously unreachable cancer cell targets. Crossbow’s efficient and selective approach is designed to target the entire universe of cancer proteins, dramatically expanding the potential of antibody therapy to address many types of cancer.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Crossbow Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Predictive Intelligence
Strategic

ML-powered predictions for Crossbow Therapeutics's next move

See what Strategic adds

Crossbow Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.